跳至主要内容
临床试验/ACTRN12621001000897
ACTRN12621001000897尚未招募4 期

Comparing the prophylactic effects of Caffeine versus placebo on the apnea of prematurity in neonates of Kabul City: A randomized clinical trial

Mansoor Aslamzai0 个研究点目标入组 130 人开始时间: 2021年7月30日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
1 Days 至 7 Days(—)
性别
All

入选标准

  • Neonates with the following criteria:
  • 1. The gestational age of 34 weeks or less.
  • 2. The birth weight less than 1500g.

排除标准

  • Neonates with the following conditions:
  • 1. Neonatal Meningitis diagnosed by CSF and complete blood count.
  • 2. Neonatal Pneumonia diagnosed by infiltration on chest x-ray and complete blood count.
  • 3. Visible CNS malformation.
  • 4. Cyanotic Congenital Heart Diseases detected by echocardiography.
  • 5. Hypoxic-ischemic encephalopathy detected by Levene or Sarnat-Sartant Scoring System.
  • 6. Severe perinatal asphyxia diagnosed as an Apgar score less than 4.
  • 7. Hypoglycemia or blood glucose level less than 40mg/dl.
  • 8. Hypocalcemia or blood calcium level less than 7.5mg/dl.
  • 9. Severe Anemia defined as hemoglobin less than 10g/dl
  • 10. Intraventricular hemorrhage detected by ultrasonography.
  • 11. Hyponatremia or serum sodium level less than 135mq/l
  • 12. Hypernatremia or serum sodium level more than 145mq/l
  • 13. Parents who declined the consents.

研究者

发起方
Mansoor Aslamzai

相似试验